Alkynyl-coumarinyl ethers as MAO-B inhibitors

被引:46
作者
Mertens, Matthias D. [1 ]
Hinz, Sonja [1 ]
Mueller, Christa E. [1 ]
Guetschow, Michael [1 ]
机构
[1] Univ Bonn, Inst Pharmaceut, D-53121 Bonn, Germany
关键词
Alkynes; Coumarins; Distribution coefficients; Mitsunobu reaction; Monoamine oxidase; MONOAMINE-OXIDASE-B; BIOLOGICAL EVALUATION; DUAL INHIBITORS; FLUORINATED PHENYLCYCLOPROPYLAMINES; PARKINSONS-DISEASE; POTENT; DERIVATIVES; 3-PHENYLCOUMARINS; ANTAGONISTS; SCAFFOLD;
D O I
10.1016/j.bmc.2014.01.046
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study, alkynyl-coumarinyl ethers were developed as inhibitors of human monoamine oxidase B (MAO-B). A series of 31 new, ether-connected coumarin derivatives was synthesized via hydroxycoumarins, whose phenolic group at position 6, 7 or 8 was converted by means of the Mitsunobu reaction. The majority of the final products were produced from primary alcohols with a terminal alkyne group. The inhibitors were optimized with respect to the structure of the alkynyloxy chain and its position at the fused benzene ring as well as the residue at position 3 of the pyran-2H-one part. A hex-5-ynyloxy chain at position 7 was found to be particular advantageous. Among the 7-hex-5-ynyloxy-coumarins, the 3-methoxycarbonyl derivative 36 was characterized as a dual-acting inhibitor with IC50 values of less than 10 nM towards MAO-A and MAO-B, and the 3-(4-methoxy) phenyl derivative 44 was shown to combine strong anti-MAO-B potency (IC50 = 3.0 nM) and selectivity for MAO-B over MAO-A (selectivity > 3400-fold). (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1916 / 1928
页数:13
相关论文
共 50 条
[31]   A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease [J].
Patil, Pravin O. ;
Bari, Sanjay B. ;
Firke, Sandip D. ;
Deshmukh, Prashant K. ;
Donda, Shailesh T. ;
Patil, Dilip A. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (09) :2434-2450
[32]   Inhibition of monoamine oxidase B by selective adenosine A2A receptor antagonists [J].
Petzer, JP ;
Steyn, S ;
Castagnoli, KP ;
Chen, JF ;
Schwarzschild, MA ;
Van der Schyf, CJ ;
Castagnoli, N .
BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (07) :1299-1310
[33]   Discovery of a Novel Class of Potent Coumarin Monoamine Oxidase B Inhibitors: Development and Biopharmacological Profiling of 7-[(3-Chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one Methanesulfonate (NW-1772) as a Highly Potent, Selective, Reversible, and Orally Active Monoamine Oxidase B Inhibitor [J].
Pisani, Leonardo ;
Muncipinto, Giovanni ;
Miscioscia, Teresa Fabiola ;
Nicolotti, Orazio ;
Leonetti, Francesco ;
Catto, Marco ;
Caccia, Carla ;
Salvati, Patricia ;
Soto-Otero, Ramon ;
Mendez-Alvarez, Estefania ;
Passeleu, Celine ;
Carotti, Angelo .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (21) :6685-6706
[34]   Antagonists for the Orphan G-Protein-Coupled Receptor GPR55 Based on a Coumarin Scaffold [J].
Rempel, Viktor ;
Volz, Nicole ;
Glaeser, Franziska ;
Nieger, Martin ;
Braese, Stefan ;
Mueller, Christa E. .
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (11) :4798-4810
[35]   7-Alkyl-3-benzylcoumarins: A Versatile Scaffold for the Development of Potent and Selective Cannabinoid Receptor Agonists and Antagonists [J].
Rempel, Viktor ;
Volz, Nicole ;
Hinz, Sonja ;
Karcz, Tadeusz ;
Meliciani, Irene ;
Nieger, Martin ;
Wenzel, Wolfgang ;
Braese, Stefan ;
Mueller, Christa E. .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (18) :7967-7977
[36]   SYNTHESIS OF COUMARINS AS SUBTYPE-SELECTIVE INHIBITORS OF MONOAMINE-OXIDASE [J].
RENDENBACHMULLER, B ;
SCHLECKER, R ;
TRAUT, M ;
WEIFENBACH, H .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (10) :1195-1198
[37]  
Riederer Peter, 2011, Exp Neurobiol, V20, P1, DOI 10.5607/en.2011.20.1.1
[38]   Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: Synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine [J].
Samadi, Abdelouahid ;
de los Rios, Cristobal ;
Bolea, Irene ;
Chioua, Mourad ;
Iriepa, Isabel ;
Moraleda, Ignacio ;
Bartolini, Manuela ;
Andrisano, Vincenza ;
Galvez, Enrique ;
Valderas, Carolina ;
Unzeta, Mercedes ;
Marco-Contelles, Jose .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 52 :251-262
[39]   Monoamine Oxidase B Inhibitors for the Treatment of Parkinson's Disease A Review of Symptomatic and Potential Disease-Modifying Effects [J].
Schapira, Anthony H. V. .
CNS DRUGS, 2011, 25 (12) :1061-1071
[40]   Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives [J].
Secci, Daniela ;
Carradori, Simone ;
Bolasco, Adriana ;
Chimenti, Paola ;
Yanez, Matilde ;
Ortuso, Francesco ;
Alcaro, Stefano .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (10) :4846-4852